Menu
Currency
GWAS Study

Genome-wide association study for circulating FGF21 in patients with alcohol use disorder: Molecular links between the SNHG16 locus and catecholamine metabolism.

Ho MF, Zhang C, Moon I et al.

35752286 PubMed ID
GWAS Study Type
442 Participants
47 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

HM
Ho MF
ZC
Zhang C
MI
Moon I
WL
Wei L
CB
Coombes B
BJ
Biernacka J
SM
Skime M
CD
Choi DS
FM
Frye M
SK
Schmidt K
GK
Gliske K
BJ
Braughton J
NQ
Ngo Q
SC
Skillon C
SM
Seppala M
OT
Oesterle T
KV
Karpyak V
LH
Li H
WR
Weinshilboum R
Chapter II

Abstract

Summary of the research findings

Objective: Alcohol consumption can increase circulating levels of fibroblast growth factor 21 (FGF21). The effects of FGF21 in the central nervous system are associated with the regulation of catecholamines, neurotransmitters that play a crucial role in reward pathways. This study aims to identify genetic variants associated with FGF21 levels and evaluate their functional role in alcohol use disorder (AUD).

442 individuals

Chapter III

Study Statistics

Key metrics and study information

442
Total Participants
GWAS
Study Type
No
Replicated
U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.